However, in hindgut-NETs examined, some cases demonstrated discrepancy between MGMT and GLUT2 status and it would be important to evaluate MGMT and GLUT2 status in tumor cells before administering STZ in GI-NET patients. Here, SLC2A2 is linked to neoplasm.